Related Experiment Video
Updated: Aug 27, 2025

Method for Measurement of Viral Fusion Kinetics at the Single Particle Level
Published on: September 7, 2009
Recent Developments in Single-Virus Fusion Assay
1Division of Virus Research and Therapeutics, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, 226031, India. souravhaldar880@gmail.com.
Viral fusion is key for infection. New single-virus assays track fusion proteins and lipid bilayer merging, overcoming limitations of older methods for antiviral drug development.
Area of Science:
- Virology
- Biophysics
- Cell Biology
Background:
- Viral infection poses a global health risk, with enveloped virus entry relying on membrane fusion.
- Membrane fusion is vital in biological processes like exocytosis, vesicular transport, and viral entry.
- Viral fusion proteins serve as models for studying membrane fusion dynamics.
Purpose of the Study:
- To review advancements in single-virus/particle fusion assays.
- To highlight the utility of these assays in understanding viral entry mechanisms.
- To use the Influenza virus as a model system for demonstrating these techniques.
Main Methods:
- Discussion of ensemble-based spectroscopic and bulk fusion assays.
- Introduction of single-virus/particle fusion assays to overcome ensemble limitations.
- Focus on assays capable of resolving molecular steps and structural changes during fusion.
Main Results:
- Single-virus assays enable synchronization of fusion events, unlike bulk methods.
- These assays allow detailed resolution of fusion pore opening and associated protein conformational changes.
- The Influenza virus model demonstrates the power of single-particle approaches.
Conclusions:
- Single-virus fusion assays provide unprecedented insights into the molecular mechanisms of viral entry.
- These advanced techniques are crucial for developing novel antiviral drugs targeting viral fusion.
- The Influenza virus paradigm illustrates the broad applicability of single-particle fusion assays.
More Related Videos
07:22A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
Published on: August 14, 2018
08:07Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
Published on: January 12, 2024